Prolonged treatment with oral retinoids in adults: No influence on the frequency and severity of spinal abnormalities

British Journal of Dermatology

Volumn 134, Issue 1, 1996, Pages 71-76

  Van Dooren Greebe, R J ^a   Lemmens, J A M ^a   De Boo, T ^a   Hangx, N M A ^a   Kuijpers, A L A ^a   Van De Kerkhof, P C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; ETRETINATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPEROSTOSIS; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN DISEASE; SPINE DISEASE;

EID: 0030034255     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1996.d01-742.x     Document Type: Article

References (30)

1. Silverman AK, Ellis CN, Voorhees JJ. Hypervitaminosis A syndrome: A paradigm of retinoid side effects. J Am Acad Dermatol 1987; 16: 1027-39.
2. Saurat JH. Side effects of systemic retinoids and their clinical management. J Am Acad Dermatol 1992; 27: S23-8.
3. Vahlquist A. Long-term safety of retinoid therapy. J Am Acad Dermatol 1992; 27: S29-33.
4. Kaplan G, Haettich B. Rheumatological symptoms due to retinoids. Baillière's Clin Rheumatol 1991; 5: 77-97.
5. Glover MT, Peters AM, Atherton DJ. Surveillance for skeletal toxicity of children treated with etretinate. Br J Dermatol 1987; 116: 609-14.
6. Halkier-Sorensen L, Laurberg G, Andresen J. Bone changes in children on long-term treatment with etretinate. J Am Acad Dermatol 1987; 16: 999-1006.
7. Wilson DJ, Kay V, Charig M et al. Skeletal hyperostosis and extraosseous calcification in patients receiving long-term etretinate (Tigason). Br J Dermatol 1988; 119: 597-607.
8. Montag M, Reiser M, Hamm H et al. Skelettveränderungen nach Langzeitbehandlung mit Retinoiden. Radiologe 1988; 28: 320-5.
9. Halkier-Sørensen L, Andresen J. A retrospective study of bone changes in adults treated with etretinate. J Am Acad Dermatol 1989; 20: 83-7.
10. Gerber LH, Helfgott RK, Gross EG et al. Vertebral abnormalities associated with synthetic retinoid use. J Am Acad Dermatol 1984; 10: 817-23.
11. DiGiovanna JJ, Helfgott RK, Gerber LH, Peck GL. Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate. N Engl J Med 1986; 315: 1177-82.
12. Melnik B, Glück S, Jungblut RM, Goerz G. Retrospective radiographic study of skeletal changes after long-term etretinate therapy. Br J Dermatol 1987; 116: 207-12.
13. Zelger B, Frank R, Kemmler G, Fritsch P. Retinoid-bedingte Veränderungen am Knochenbandapparat. Hautarzt 1990; 41: 537-44.
14. Gilbert M, Ellis CN, Voorhees JJ. Lack of skeletal radiographic changes during short-term etretinate therapy for psoriasis. Dermatologica 1986; 172: 160-3.
15. Kilcoyne RF. Effects of retinoids in bone. J Am Acad Dermatol 1988; 19: 212-6.
16. Török L, Galuska L, Kása M, Kádár L. Bone-scintigraphic examinations in patients treated with retinoids: a prospective study. Br J Dermatol 1989; 120: 31-6.
17. Mørk NJ, Kolbenstvedt A, Austad J. Efficacy and skeletal side effects of two years acitretin treatment. Acta Derm Venereol (Stockh) 1992; 72: 445-8.
18. Hohl D, Pelloni F, Sigg C et al. A prospective study of skeletal changes during short-term acitretin therapy. Dermatology 1992; 185: 23-6.
19. Kullavanijaya P, Kulthanan K. Clinical efficacy and side effects of acitretin on the disorders of keratinization: a one-year study. J Dermatol 1993; 20: 501-6.
20. Resnick D, Niwayama G. Diagnosis of Bone and Joint Disorders, 2nd edn. Philadelphia: WB Saunders 1988; 1161.
21. Resnick D, Niwayama G. Diagnosis of Bone and Joint Disorders, 2nd edn. Philadelphia: WB Saunders 1988; 1564-5.
22. Tothill P. Methods of bone mineral measurements. Phys Med Bio 1989; 31: 546-50.
23. Julkunen H, Heinonen OP, Knekt P, Maatela J. The epidemiology of hyperostosis of the spine together with its symptoms and related mortality in a general population. Scand J Rheumatol 1975; 4: 23-7.
24. Resnick D, Niwayama G. Radiographic and pathologic features of spinal involvement in DISH. Radiology 1976; 119: 559-68.
25. Boachie-adjei O, Bullough PG. Incidence of ankylosing hyperostosis of the spine (Forestier's disease) at autopsy. Spine 1987; 12: 739-43.
26. Ellis CN, Voorhees JJ. Etretinate therapy. J Am Acad Dermatol 1987; 16: 267-89.
27. Melnik B, Plewig G. Unerwünschte Knochenveränderungen unter systemischer Behandlung mit synthetischen Retinoiden. Hautartzt 1987; 38: 193-7.
28. Orfanos CE, Ehlert R, Gollnick H. The retinoids. A review of their clinical pharmacology and therapeutic use. Drugs 1987; 34: 459-503.
29. White SI, MacKie RM. Bone changes associated with oral retinoid therapy. Pharm Ther 1989; 40: 137-44.
30. Dooren-Greebe RJ van, Kerkhof PCM van de. Extensive extraspinal hyperostoses after long-term oral retinoid treatment in a patient with pityriasis rubra pilaris. J Am Acad Dermatol 1994; 32: 322-5.